Sek srautus: tinklaraščius, naujienas, RSS ir daugiau. Lengvas būdas skaityti ir įsisavinti pasirinktą turinį.
Gauti FeederFeeder naudotojų dažniausiai sekami Farmacija RSS kanalai, įskaitant Mineralys Therapeutics, Inc. (MLYS) Press Releases, News ir PTC Therapeutics, Inc. News Releases. Nukopijuokite kanalo URL arba sekite juos nemokamai per Feeder.
Sveikata RSS kanalai Onkologija RSS kanalai Klinikiniai tyrimai RSS kanalai Medicininiai tyrimai RSS kanalai Psichikos sveikata RSS kanalai Psichologija RSS kanalai Visuomenės sveikata RSS kanalai
Pasiūlyti pataisąDailyMed provides high quality information about marketed drugs. Drug labeling on this Web site is the most recent submitted to the Food and Drug Administration (FDA) and currently in use; it may include strengthened warnings undergoing FDA review and minor editorial changes.
New contents from the website www.hma.eu. Category: Recently Published CMDh
Studies found on ClinicalTrials.gov by a search of: Other terms: NCT06087835 | Last update posted in the last 14 days
New drug approvals news from Drugs.com. Comprehensive, up-to-date drug news for consumers and healthcare professionals.
Leading the way in life science technologies
Headline news from Drugs.com. Comprehensive, up-to-date drug news for healthcare professionals.
Biotech news: Inside the discoveries, personalities, and deals driving drug development in general and biomedical engineering in particular. Sign up for <a href="https://www.statnews.com/signup/readout/">The Readout</a> newsletter to get the latest on biotech delivered to your inbox.
Die aktuellsten Meldungen aus Gesundheitspolitik und Medizin
Business Wire - The global leader in news distribution
Altroconsumo è un'associazione di consumatori, la prima e la più diffusa in Italia con i suoi 300.000 Soci. Indipendente e senza fini di lucro, ha un unico obiettivo: l'informazione e la tutela dei consumatori.
The latest news released by Cellectar Biosciences, Inc. (CLRB)
The latest news released by Medexus Pharmaceuticals, Inc. (MDP)
Developing the next generation of oncology therapies for patients.